Evenity (romosozumab-aqqg) - Astellas, Amgen, UCB
Real-World Romosozumab Utilization Patterns Among Medicare Beneficiaries: A Multistate Analysis (ACR Convergence 2026) - Sep 8, 2026 - Abstract #629; Pres time: Nov 8, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available 
Clinical • Medicare • Real-world • Real-world evidence • Reimbursement • US reimbursement • Orthopedics • Osteoporosis • Rheumatology
https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3569856
 
Ye Liu, MD, MPH, DrPH
 
Sep 8, 2026
 
Prev Next